Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
American Society of Hematology (ASH 2026)12 - 15 December 2026
Concizumab prophylaxis in children with hemophilia A or B with inhibitors: Clinical outcome assessment results from observer-reported questionnaires in the phase 3 explorer10 study
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.